Inactive Instrument

Alexza Pharmaceuticals, Inc. Stock Nasdaq

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

16-03-28	Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	PU
16-03-15	Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	PU
16-03-09	Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	PU
16-02-26	Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	PU
16-02-24	Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	PU

15-12-22	Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains
15-12-22	USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Mario Rovirosa Escosura CEO	Chief Executive Officer	-	-
Stacy Palermini DFI	Director of Finance/CFO	-	2002-12-31
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	2019-04-30

Director	Title	Age	Since
Jorge Ramentol Massana BRD	Director/Board Member	-	2016-06-20
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	2016-06-20
Joan Fanés Trillo BRD	Director/Board Member	-	2016-06-20

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+8.49%	+20.55%	+70.77%	+110.32%	68.12B
ARGENX SE	+1.25%	+2.44%	+34.27%	+70.43%	55.18B
INSMED INCORPORATED	-1.09%	+32.96%	+19.67%	+494.56%	28.63B
WUXI BIOLOGICS (CAYMAN) INC.	+10.83%	+18.38%	+56.20%	+6.03%	23.99B
BIONTECH SE	+2.72%	+3.41%	-16.11%	-7.96%	23.53B
GENMAB A/S	+6.50%	+7.56%	+44.65%	-21.73%	18.45B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.20%	+11.51%	+33.87%	+693.38%	16.44B
PHARMAESSENTIA CORPORATION	-3.88%	+16.98%	+199.30%	+359.77%	15.83B
EXELIXIS, INC.	+3.58%	+1.96%	+43.35%	+163.76%	13.4B
Average	+3.84%	+11.68%	+54.00%	+207.62%	29.28B
Weighted average by Cap.	+4.36%	+13.10%	+50.69%	+168.47%

Employees

Sector